Skip to main content
. 2006 Aug 10;66(3):419–421. doi: 10.1136/ard.2006.054098

graphic file with name ar54098.f1.jpg

Figure 1 ASessments in Ankylosing Spondylitis (ASAS) 20% and 40% response and ASAS criteria for partial remission (PR) and Bath Ankylosing Spondylitis Disease Activity (BASDAI) 20%, 50% and 70% improvement in patients with active ankylosing spondylitis after 16 weeks of treatment with methotrexate.